View in EDS

Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.

Saved in:
Bibliographic Details
Title: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Authors: Rascol, Olivier1 (AUTHOR), Tönges, Lars1,2,3 (AUTHOR) lars.toenges@ruhr-uni-bochum.de, deVries, Tina4 (AUTHOR), Jaros, Mark4,5 (AUTHOR), Quartel, Adrian6 (AUTHOR), Jacobs, David4 (AUTHOR), ALLAY-LID I and ALLAY-LID II study groups (CORPORATE AUTHOR)
Source: Parkinsonism & Related Disorders. Mar2022, Vol. 96, p65-73. 9p.
Database: Academic Search Ultimate
Description
ISSN:13538020
DOI:10.1016/j.parkreldis.2022.01.022